3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 3-(5-甲基-3-异噁唑基)-6-[(1-甲基-1H-1,2,3-三氮唑-4-基)甲氧基][1,2,4]三氮唑并[3,4-a]酞嗪
CAS 215874-86-5 MFCD09832717
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Agonists, Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, GABAergics, Merck, Neuroscience, Neurotransmission, Neurotransmitters
- {SNA} Agonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Diversification Ready Pharma-Developed Compounds, GABAergics, I, Merck & Co., Neuroscience, Neurotransmission, Neurotransmitters, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- {SNA} Agonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index,